Century Therapeutics, Inc.
Developing iPSC-derived, off-the-shelf cell therapies for cancer & autoimmune diseases.
IPSC | NDAQ
Overview
Corporate Details
- ISIN(s):
- US15673T1007
- LEI:
- Country:
- United States of America
- Address:
- 25 N 38TH STREET, 11TH FLOOR, 19104 PHILADELPHIA
- Website:
- https://www.centurytx.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Century Therapeutics, Inc. is a clinical-stage biotechnology company developing allogeneic, 'off-the-shelf' cell therapies for cancer and autoimmune diseases. The company's platform is based on induced pluripotent stem cells (iPSCs), which have an unlimited self-renewing capacity. By utilizing cutting-edge cellular engineering and manufacturing, Century Therapeutics aims to create precisely designed natural killer (NK) and T cell therapies. These products are intended to be more effective, tolerable, and accessible than existing treatments, overcoming the limitations of conventional cell therapies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Century Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Century Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Century Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
